DuPont de Nemours, Inc. research snapshot
DD AI stock analysis currently reads DuPont de Nemours as a reshaped specialty materials company after the Qnity Electronics separation. The July 8, 2026 data cutoff shows a stronger continuing-operations profile than the headline GAAP loss implies: Q1 2026 net sales rose 4% to $1.681 billion, operating EBITDA rose 15%, and management raised 2026 guidance. At $139.61 and about $18.85 billion in market value, DD trades near 19.2x forward EPS, 2.72x sales, 1.36x book value, and 20.9x free cash flow. The DD AI stock forecast is scenario-based, not a precise price prediction, because the biggest question is whether Healthcare & Water Technologies and Diversified Industrials can compound after the portfolio reset without new separation, PFAS, construction, or tariff shocks.
Current price
$139.61
Market cap
$18.85 billion verified market cap
AI score
61 / 100
Rating
Focused specialty materials franchise with post-separation execution and valuation risk
Trend status
Mixed trend, price below the 50-day and 200-day averages but still above the post-spin trough
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | DuPont sells specialized materials, water technologies, healthcare packaging, biopharma materials, building products, and industrial solutions where qualification, reliability, and process know-how matter. | Medium-high |
| Moat | The moat comes from application engineering, customer qualification cycles, product performance, regulatory know-how, water technology, and switching costs in critical industrial workflows. | Medium-high |
| Management | Lori Koch became CEO in June 2024 after serving as CFO and has led a portfolio reset through Qnity separation, Aramids divestiture, buybacks, and a narrower operating focus. | Medium |
| Financial trend | FY2025 continuing net sales were $6.849 billion, up 2%, with continuing income of $98 million. Q1 2026 sales rose 4% and continuing income improved to $150 million. | High |
| Valuation | At $139.61, DD trades near 19.2x forward EPS, 2.72x sales, 1.36x book value, 20.9x free cash flow, and 13.75x EV to EBITDA. | High |
| Technical trend | The stock is below StockAnalysis 50-day and 200-day moving averages, with RSI near neutral and support concentrated around the high $130s. | Medium |
| Risk level | Main risks are post-spin complexity, PFAS and legacy liabilities, construction weakness, tariff and input cost pressure, balance-sheet leverage, and multiple compression. | Medium-high |
| AI confidence | Descriptive data confidence is high, but normalized earnings confidence is only medium because the company is still settling into its post-Qnity base. | High data, medium forecast |
| Investment certainty | The current price can work if DuPont converts the portfolio reset into durable growth and cash flow, but the margin of safety is not obvious after the stock recovery. | Medium |
DD AI stock forecast
The DD AI stock forecast uses the $139.61 price reference, about $7.27 forward EPS implied by StockAnalysis forward PE, and a three-year scenario model. The audited model produced a bullish area near $222.60, a base area near $164.50, and a bearish area near $95.80 before dividends. This range reflects specialty-materials quality plus the uncertainty of post-separation earnings power.
$205 to $230
More likely if Healthcare & Water Technologies keeps growing, Diversified Industrials stabilizes construction exposure, operating EBITDA margins expand, Aramids proceeds strengthen capital allocation, and investors pay around 23x higher normalized EPS.
$155 to $170
More likely if DD compounds EPS near a mid-single-digit rate, free cash flow stays close to current levels, PFAS and separation liabilities remain manageable, and the market values the company near 19x earnings.
$90 to $105
More likely if construction and industrial demand weakens, tariff costs are not recovered, cash conversion slips, legacy liabilities expand, or the market re-rates DD toward a lower specialty-chemicals multiple.
DD AI technical analysis
DD AI technical analysis is mixed as of the July 8, 2026 cutoff. StockAnalysis listed a July 7 close of $139.61, a 50-day moving average of $142.52, a 200-day moving average of $151.26, RSI of 47.70, and 20-day average volume near 1.48 million shares. Investing.com showed a similar 50-day area near $137.28 but a lower 200-day reference near $141.27, so the practical setup is to separate a reclaim of the low $140s from a failure below the high $130s.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $139.61 | StockAnalysis real-time quote reference at the July 7, 2026 close, used for the market-cap and valuation checks. |
| Immediate support | $136 to $138 | A nearby support band around recent trading and the high end of the post-pullback area. |
| Deeper support | $128 to $132 | A larger reset zone that would test whether post-spin buyers still defend DD after the one-year recovery. |
| Near resistance | $142 to $143 | StockAnalysis 50-day moving average and several vendor references cluster around this area. |
| Major resistance | $151 to $158 | StockAnalysis 200-day moving average and the 52-week high area form the next heavier resistance zone. |
| Moving averages | 50-day near $142.52, 200-day near $151.26 | Price below both references keeps the near-term technical label mixed to cautious. |
| Momentum | RSI near 47.70 | Momentum is neutral rather than deeply oversold, so price confirmation matters more than one-day rebounds. |
| Volume | 20-day average near 1.48 million shares | A reclaim of resistance should be more credible if it occurs on volume above this baseline. |
| Volatility | Watch Q2 earnings, guidance, tariffs, and separation costs | The next update can move the stock because normalized earnings power is still being reset after Qnity. |
| Invalidation | Close below $136, then below $128 | A first break would weaken the short-term setup. A second break would challenge the recovery trend. |
DD AI trading strategy
The DD AI trading strategy below is a rules-based research framework, not personal advice. It connects the chart with post-spin financial execution, Healthcare & Water Technologies growth, Diversified Industrials demand, free cash flow, PFAS and legacy liabilities, buybacks, and valuation discipline.
Watch for DD to reclaim the $142 to $143 area, then hold above it while Q2 results confirm organic sales growth, operating EBITDA margin stability, and clean cash conversion.
A failed reclaim followed by a close below $136 should reduce trend confidence, especially if management lowers guidance or cites tariff pressure.
If DD pulls back toward $128 to $132 without deterioration in water, healthcare, or industrial order quality, compare the lower price with forward earnings and free cash flow yield.
Do not treat a lower price as automatically attractive if PFAS, separation, or discontinued-operation liabilities expand faster than operating cash flow.
Track Healthcare & Water Technologies sales, Diversified Industrials margin, adjusted EPS guidance, transaction-adjusted free cash flow, total debt, buybacks, dividend coverage, and Aramids proceeds.
Position sizing should reflect that DD is a post-restructuring specialty materials company, not a stable utility or a guaranteed compounder.
Investment research summary
Customers pay DuPont for specialized materials and technology that improve reliability, safety, filtration, packaging, construction performance, transportation durability, and industrial process outcomes.
The moat is strongest where DD products are qualified into customer processes, where replacement risk is costly, and where engineering support, patents, materials science, and regulatory knowledge matter more than commodity price.
The thesis fails if post-spin earnings power is overstated, PFAS or legacy liabilities absorb cash, construction markets stay weak, tariffs pressure margins, or management uses buybacks before the balance sheet and portfolio are fully settled.
Lori Koch brings finance and portfolio experience from inside DuPont. The test is whether the team can turn the Qnity separation and Aramids sale into a simpler company with cleaner cash flow and better capital allocation.
DuPont participates in healthcare packaging, biopharma materials, water treatment, industrial safety, construction, automotive, and aerospace markets. These are useful long-duration niches, but they are not immune to capex cycles, tariffs, regulation, and housing demand.
At $139.61, DD is not priced like a distressed chemical stock. Margin of safety depends on the company proving that normalized EPS can grow from the post-separation base while free cash flow covers dividends, buybacks, and liabilities.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| DD quote reference | $139.61 close on July 7, 2026 | StockAnalysis DD statistics | July 8, 2026 |
| Market capitalization verification | $18.85 billion reported, $18.85 billion calculated from $139.61 x 135.02 million shares | Pineify financial_rigor.py and StockAnalysis statistics | July 8, 2026 |
| Shares outstanding | 135.02 million shares outstanding | StockAnalysis DD statistics | July 8, 2026 |
| FY2025 continuing net sales | $6.849 billion, up 2% versus 2024 | DuPont FY2025 results release | July 8, 2026 |
| FY2025 continuing income | $98 million GAAP income from continuing operations | DuPont FY2025 results release | July 8, 2026 |
| Q1 2026 sales and earnings | $1.681 billion net sales, $150 million GAAP income from continuing operations, and $0.55 adjusted EPS | DuPont Q1 2026 results release | July 8, 2026 |
| Q1 2026 segment sales | $806 million Healthcare & Water Technologies and $875 million Diversified Industrials | DuPont Q1 2026 segment table | July 8, 2026 |
| Cash and debt | $710 million cash and equivalents, $3.172 billion total debt, and $2.462 billion net debt | DuPont Q1 2026 release and StockAnalysis balance sheet | July 8, 2026 |
| Free cash flow | $901 million TTM free cash flow and $6.67 FCF per share | StockAnalysis DD statistics | July 8, 2026 |
| Valuation ratios | Forward PE 19.21, price to sales 2.72, price to book 1.36, EV to EBITDA 13.75, and price to free cash flow 20.92 | StockAnalysis DD statistics | July 8, 2026 |
| Technical references | 50-day moving average $142.52, 200-day moving average $151.26, RSI 47.70, and 20-day average volume 1.48 million | StockAnalysis DD statistics | July 8, 2026 |
| Qnity separation | Qnity Electronics separation completed on November 1, 2025, with DuPont shareholders receiving one Qnity share for every two DuPont shares held on the record date | DuPont Qnity separation release | July 8, 2026 |
This DD AI stock analysis is an informational research tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available public data as of July 8, 2026 and can be wrong if earnings, valuation multiples, technical trends, liabilities, or market conditions change.
